Ebola

Viral hemorrhagic fever of humans and other primates caused by ebolaviruses

Follow Ebola on Notably News to receive short updates to your email — rarely!

We include updates on Peter Piot, Bellevue Hospital, The Hot Zone, William Close, Executive Orders, After the Dark, Mayinga N'Seka, Ameyo Adadevoh, 93 Days, Royal Free Hospital, Favipiravir, Oslo University Hospital, Nebraska Medicine, Yambuku, Western red colobus, FGI-104 ... and more.

February 2024
Favipiravir
A Cochrane Systematic review concluded that Favipiravir shows no significant benefits in treating COVID-19, with no improvements in mortality, mechanical ventilation, or hospitalization rates.
January 10 2023 The Uganda Ebola outbreak was declared over after 42 days with no new cases, having killed nearly 80 people.
2022 In Uganda, lighter personal protection equipment was introduced, along with new patient monitoring techniques that allow healthcare workers to communicate with patients through treatment tent windows before entering, improving safety protocols for Ebola care.
October 2022 The number of Ebola cases in Uganda increased to 63.
September 2022 Uganda reported 7 initial cases of Ebola Sudan strain.
August 15 2022 The fifth Ebola case was buried in the DRC outbreak.
July 4 2022 The DRC Ebola outbreak was officially declared over, 42 days after the last case.
May 24 2022 By this date, 5 recorded deaths from Ebola were reported in the DRC.
April 23 2022 A case of Ebola was confirmed in the Democratic Republic of the Congo (DRC) in the Equateur province, involving a 31-year-old man who initially did not seek treatment and died on the same day of admission to an Ebola treatment centre.
August 31 2021 The World Health Organization (WHO) determined through further laboratory tests in Lyon that the patient did not actually have Ebola, with the original cause of the patient's disease remaining under investigation.
August 14 2021 The Ministry of Health of Cote d'Ivoire confirmed the country's first suspected Ebola case since 1994, with samples from a patient hospitalized in Abidjan after arriving from Guinea.
June 19 2021 The Ebola outbreak in Guinea was officially declared over, with a total of 23 reported cases.
May 8 2021 A 42-day countdown period commenced to monitor for potential new Ebola cases in Guinea.
May 3 2021 The 12th Ebola Virus Disease (EVD) outbreak was declared over, resulting in 12 total cases and six deaths. Heightened surveillance was to continue for 90 days after the declaration to monitor for potential resurgence.
April 3 2021 No new Ebola cases or deaths were reported after this date in the Guinea outbreak.
February 2021 Sakoba Keita, head of Guinea's national health agency, confirmed three Ebola deaths in the south-eastern region near Nzérékoré, with five additional positive cases reported.
February 14 2021 The Guinean government officially declared an Ebola epidemic, potentially triggered by a reactivation of a latent case in a previous outbreak survivor.
February 12 2021 A third Ebola case was detected in Butembo.
February 11 2021 A second woman who had contact with the previous Ebola patient died in Butembo, and the number of traced contacts increased to 100.
February 7 2021 Congolese health ministry announced a new Ebola case near Butembo, North Kivu. The case was a 42-year-old woman who developed symptoms on 1 February 2021 and died in a hospital in Butembo. Over 70 people who had contact with her were tracked by WHO.
2020 Conclusion of the Kivu Ebola epidemic, with approximately 345,000 people vaccinated during this period.
2020
Western African Ebola epidemic
Paul Farmer reviewed pandemic information, noting significantly lower death rates among U.S. and European patients due to optimal medical care.
November 19 2020 The 11th Ebola Virus Disease (EVD) outbreak in Équateur Province was officially declared over, with a total of 130 confirmed cases, 75 recoveries, and 55 deaths.
October 2020 The U.S. Food and Drug Administration (FDA) approved atoltivimab/maftivimab/odesivimab for the treatment of Zaire ebolavirus infection, marking a significant advancement in Ebola treatment.
September 2020
Favipiravir
Coronavir received approval for prescription sales for outpatient use in Russia, expanding its accessibility for COVID-19 treatment.
September 2020
Favipiravir
A rapid meta-review analyzed four studies on Favipiravir, finding clinical and radiological improvements in COVID-19 treatment, but no reduction in mortality or oxygen-support requirement.
July 2020
Favipiravir
Coronavir (brand name of favipiravir) was approved for use in Russian hospitals to treat COVID-19.
June 25 2020 The second biggest Ebola Virus Disease (EVD) outbreak was officially declared over.
June 15 2020 Case count increased to 17 with 11 deaths, and over 2,500 people had been vaccinated as part of the outbreak response.
June 1 2020 Congolese health ministry announced a new Ebola outbreak in Mbandaka, Équateur Province, with 6 initial cases and 4 deaths. The outbreak was the 11th in the Democratic Republic of Congo since the virus was first discovered in 1976.
2019
Favipiravir
Favipiravir became a generic drug, potentially increasing its accessibility and affordability for patients.
2019
Western African Ebola epidemic
rVSV-ZEBOV received regulatory approval as an Ebola vaccine.
2019
Western African Ebola epidemic
rVSV-ZEBOV vaccine received regulatory approval.
July 2019 An infected man travelled to Goma, a city with over two million inhabitants.
July 17 2019 The World Health Organization (WHO) declared the Ebola outbreak a global health emergency, marking the fifth such declaration in the organization's history. A government spokesman noted that half of the Ebola cases were unidentified and the outbreak could potentially last up to three years.
June 2019 Two people died of Ebola in neighbouring Uganda.
March 2019 The outbreak became the second largest Ebola outbreak ever recorded, with more than 1,000 cases and continued insecurity hindering response efforts.
November 2018 Nearly 200 Congolese had died of Ebola, with about half of the deaths occurring in the city of Beni, where armed groups were fighting over the region's mineral wealth and impeding medical relief efforts.
August 1 2018 The world's 10th Ebola outbreak was declared in North Kivu province of the Democratic Republic of the Congo, marking the first Ebola outbreak in a military conflict zone with thousands of refugees present.
July 24 2018 The 2018 Ebola outbreak in the Democratic Republic of Congo was officially declared over.
April 2018
Western African Ebola epidemic
rVSV-ZEBOV Ebola vaccine was used for the first time to successfully stop an Ebola outbreak in the Équateur province of the Democratic Republic of the Congo.
April 4 2018 Start of Ebola outbreak in Democratic Republic of Congo's Équateur province, with 39 suspected, probable, or confirmed cases reported by 14 May, including 19 deaths.
May 2017 A new Ebola outbreak began in the Democratic Republic of the Congo.
2016
Favipiravir
Fujifilm licensed Favipiravir to Zhejiang Hisun Pharmaceutical Co., expanding its potential global distribution and research opportunities.
December 2016
Western African Ebola epidemic
Publication of two-year Guinea trial results confirmed that rVSV-ZEBOV vaccine protects people exposed to Ebola cases and provides herd immunity.
December 2016
Western African Ebola epidemic
WHO announced results of a two-year trial of the rVSV-ZEBOV vaccine, which appeared to offer protection from the Ebola virus variant responsible for the Western Africa outbreak.
September 2016
Western African Ebola epidemic
A study suggested that the Ebola virus may persist in seminal fluid for more than 530 days after infection.
September 2016
Western African Ebola epidemic
Findings published suggested the Ebola resurgence was caused by a survivor who, after eight months of abstinence, had sexual relations with multiple partners.

We are only showing the most recent entries for this topic.

This contents of the box above is based on material from the Wikipedia articles Ebola, Western African Ebola epidemic & Favipiravir, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also